974
FLUORESCENTLY LABELLED VEDOLIZUMAB IDENTIFIED MACROSCOPIC AND MICROSCOPIC MUCOSAL DRUG DISTRIBUTION AND TARGET CELLS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Date
May 9, 2023
Explore related products in the following collection:
Tracks
Related Products
LIMITED RISK OF RESIDUAL CANCER AFTER ENDOSCOPIC RESECTION OF EARLY BARRETT'S NEOPLASIA WITH CONFIRMED VERTICAL R1 MARGIN: A NATIONWIDE COHORT IN THE NETHERLANDS
Current guidelines advise esophagectomy for submucosal esophageal adenocarcinoma (T1b EAC). However, data from retrospective studies suggest that endoscopic follow-up (FU) may be a valid alternative in patients without signs of lymph node metastases (LNM) at baseline…
ULTRASOUND-GUIDED NEEDLE BIOPSY FLUORESCENCE SPECTROSCOPY WITH QUANTITATIVE FLUORESCENCE ENDOSCOPY FOR RESPONSE MONITORING IN PATIENTS WITH ESOPHAGEAL CANCER AFTER NEOADJUVANT CHEMORADIOTHERAPY USING BEVACIZUMAB-800CW
BACKGROUND: Using EsoCheck (EC), a non-endoscopic balloon device for sampling the distal esophagus, coupled with EsoGuard (EG), a DNA based testing screening for Barrett’s esophagus (BE), we have previously reported high sensitivity and specificity for detection of BE among patients with known BE c…
PRO-CON DEBATE: PRO-GJ - EUS-GI IS THE NEW STANDARD
EUS-guided gastroenterostomy (EUS-GE) is a novel method for palliating gastric outlet obstructon due to unresectable malignancies…
ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ADENOCARCINOMA IN BARRETT’S ESOPHAGUS: INTERIM RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)
Current guidelines advise esophagectomy for submucosal esophageal adenocarcinoma (T1b EAC). However, data from retrospective studies suggest that endoscopic follow-up (FU) may be a valid alternative in patients without signs of lymph node metastases (LNM) at baseline…